Former Chief Medical Officer · Fulcrum Therapeutics, Inc. (FULC)

Patrick Horn

FY2024 is the first fiscal year CompBrief holds for Patrick Horn as a named executive officer of Fulcrum Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$3,730,273

Salary $395,833Stock awards $0

1st of 4 named executive officers at Fulcrum Therapeutics by FY2024 total.

4 named officers on file for Fulcrum Therapeutics, FY2024

Patrick Horn’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Fulcrum Therapeutics’s whole pay program stands against its peers

  • Fulcrum Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FULC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A).

Free

Get Patrick Horn’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Patrick Horn compensation by year

Fulcrum Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Fulcrum Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$395,833
Bonus$0
Stock awards$0
Option awards$3,334,440
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$3,730,273

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulcrum Therapeutics, Inc. DEF 14A filed April 30, 2025, accession 0000950170-25-061000, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Fulcrum Therapeutics, Inc. filed document, accession 0000950170-25-061000. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

Fulcrum Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Patrick Horn · this pageFormer Chief Medical Officer$3,730,273
Curtis OltmansChief Legal Officer$1,425,240
Alan MussoChief Financial Officer$1,251,760
Alex SapirPresident and Chief Executive Officer$1,003,300

The full Fulcrum Therapeutics compensation record

free company brief

This page is one person within Fulcrum Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Fulcrum Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Patrick Horn's compensation dossier · One-time report. No refunds.